Ems
Clinical trials sponsored by Ems, explained in plain language.
-
New combo pill aims to slash dangerous blood fats
Disease control CompletedThis study tested a drug called Cipros 20 in 406 adults with dyslipidemia (abnormal fat levels in the blood) who also had high heart disease risk. The goal was to see if it lowers triglycerides and LDL cholesterol more effectively than a placebo. Participants took the medication …
Phase: PHASE3 • Sponsor: EMS • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
New combo pill aims to lower dangerous blood fats
Disease control CompletedThis study tested a medication called Cipros 10 in 146 adults with high triglycerides and cholesterol. The goal was to see if it safely lowers blood fat levels. Participants took the drug or a placebo for a set period, and researchers measured changes in triglycerides and tracked…
Phase: PHASE3 • Sponsor: EMS • Aim: Disease control
Last updated Jun 10, 2026 13:28 UTC
-
New combo pill aims to restore sexual function in men with prostate trouble
Symptom relief CompletedThis study tested a drug called Tanzânia in 295 men who have both erectile dysfunction and an enlarged prostate (benign prostatic hyperplasia). The goal was to see if the drug improves erectile function better than a placebo. Participants took the drug or a dummy pill for a perio…
Phase: PHASE3 • Sponsor: EMS • Aim: Symptom relief
Last updated Jun 15, 2026 19:02 UTC